Combination Therapy Slows Pediatric Bone Cancer in Preclinical Models
Published in the Journal of Experimental Medicine, researchers co-led by St. Jude Children’s Research Hospital have identified a preclinical therapeutic combination that targets EP300 and inhibits AKT, successfully slowing pediatric … Read More